Table 1 Demographics and serostatus of study participants
 | n | Age in years, median (range) | Sex | Infection >6 monthsa |
---|---|---|---|---|
Adults | ||||
All | 154 | 40 (20–71) | 19% Male 81% Female | – |
Seropositive | 91 | 39 (20–71) | 18% Male 82% Female | 81 |
Seronegative | 63 | 43 (26–65) | 21% Male 79% Female | – |
Children | ||||
All | 91 | 7 (3–11) | 52% Male 48% Female | – |
Seropositive | 43 | 8 (5–11) | 67% Male 33% Female | 35 |
Seronegative | 48 | 7 (3–11) | 53% Male 47% Female | – |